![Niels Reichardt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Niels Reichardt
Former positions of Niels Reichardt
Companies | Position | Start | End |
---|---|---|---|
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Chief Tech/Sci/R&D Officer | 31/12/2005 | 31/12/2005 |
CICbiomagune institute | Corporate Officer/Principal | 31/12/2005 | - |
Metabolic Renal Disease SL
![]() Metabolic Renal Disease SL Medical SpecialtiesHealth Technology Metabolic Renal Disease SL develops mass-spectrometry based tools for targeted metabolomics. It is a biotechnology company that specializes in the field of biometrics. The company's activity is centered in the development of analytical tools based in mass spectrometry and oriented to metabolomics for the identification, quantification and interpretation of metabolites in biofluids. The firm offers a range of applications, specially related to toxicology and pharmacological evaluation. Metabolic Renal Disease was founded in 2008 and is headquartered in San Sebastian, Spain. | Chief Tech/Sci/R&D Officer | 07/10/2009 | - |
Training of Niels Reichardt
Universität Konstanz | Doctorate Degree |
Statistics
International
Spain | 3 |
United Kingdom | 2 |
Germany | 2 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
Metabolic Renal Disease SL
![]() Metabolic Renal Disease SL Medical SpecialtiesHealth Technology Metabolic Renal Disease SL develops mass-spectrometry based tools for targeted metabolomics. It is a biotechnology company that specializes in the field of biometrics. The company's activity is centered in the development of analytical tools based in mass spectrometry and oriented to metabolomics for the identification, quantification and interpretation of metabolites in biofluids. The firm offers a range of applications, specially related to toxicology and pharmacological evaluation. Metabolic Renal Disease was founded in 2008 and is headquartered in San Sebastian, Spain. | Health Technology |
CICbiomagune institute |
- Stock Market
- Insiders
- Niels Reichardt
- Experience